Spot 14 Antibodies

Santa Cruz Biotechnology delivers a wide array of Spot 14 Antibodies for advanced research in molecular biology. Spot 14 Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Spot 14, also known as thyroid hormone-responsive protein, plays a crucial role in lipid metabolism and is involved in the regulation of fatty acid synthesis. Its expression is influenced by thyroid hormones, making it an important marker for studying metabolic disorders and thyroid function. Understanding Spot 14's role in cellular processes can provide insights into obesity, diabetes, and other metabolic diseases. Spot 14 monoclonal antibodies enable researchers to investigate lipid metabolism pathways and their regulation in various cell types. Studying Spot 14 expression patterns helps reveal its involvement in energy homeostasis and metabolic signaling networks. Research focusing on Spot 14 continues to uncover new aspects of metabolic regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for Spot 14 support researchers worldwide in advancing our understanding of metabolic diseases and potential treatments.